<qa>  What is the goal of this study?The goal of this study is to determine the short term safety 30 days and efficacy 6 months of the heterotopic implantation of the Edwards-Sapien XT valve in the inferior vena cava for the treatment of severe tricuspid regurgitation in patients who are inoperable or at a very high surgical risk for tricuspid valve replacement. 